Fatal disseminated infection due to Scedosporium prolificans in a patient with acute myeloid leukemia and posaconazole prophylaxis

Leukemia and Lymphoma

Volumn 52, Issue 8, 2011, Pages 1607-1610

  Rivier, Alexandre ^a,b   Perny, Jessica ^a   Debourgogne, Anne ^a,b   Thivillier, Carine ^a   Lévy, Bruno ^a   Gérard, Alain ^a   MacHouart, Marie ^a,b  

^a CHU NANCY BRABOIS   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; CHLORAMPHENICOL; CIPROFLOXACIN; CREATININE; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; TEICOPLANIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ANTIBIOTIC THERAPY; CANDIDA GLABRATA; CASE REPORT; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG DOSE REDUCTION; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FATAL DISSEMINATED INFECTION; FATALITY; FEBRILE NEUTROPENIA; FEBRILE SYNDROME; FEVER; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; HYPERURICEMIA; IMMUNOCOMPETENCE; INTENSIVE CARE UNIT; INTESTINE OBSTRUCTION; LETTER; LUNG LAVAGE; MALE; MYCOSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROPHYLAXIS; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; SCEDOSPORIUM PROLIFICANS INFECTION;

ACUTE DISEASE; AGED; ANTIFUNGAL AGENTS; FATAL OUTCOME; HUMANS; LEUKEMIA, MYELOID; MALE; MYCOSES; SCEDOSPORIUM; TRIAZOLES;

EID: 79960407118     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.573034     Document Type: Letter

References (17)

1. Cortez KJ, Roilides J, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008;21:157-197
2. Kaltseis J, Rainer J, De Hoog GS. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environment and their distribution in clinical samples. Med Mycol 2009;47:398-405
3. Harun A, Perdomo H, Gilgado F, et al. Genotyping of Scedosporium species: a review of molecular approaches. Med Mycol 2009;47:406-414
4. Rodriguez-Tudela JL, Berenguer J, Guarrot J, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol 2009;47:359-370
5. Grenouillet F, Botterel F, Crouzet J, et al. Scedosporium prolificans: an emerging pathogen in France? Med Mycol 2009;47:343-350
6. Maertens J, Lagrou K, Deweerdt H, et al. Disseminated infection by Scedosporium prolificans: an emerging fatality among hematology patients. Case report and review. Ann Hematol 2000;9:340-344 (Pubitemid 30349029)
7. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-1821
8. Senn L, Robinson JO, Schmidt S, et al. 1,3-b-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008;46:878-875
9. Mousset S, Bug G, Heinz WJ, Tintelnot K, Rickerts V. Breakthrough zygomycosis on posaconazole prophylaxis after allogenic stem cell transplantation. Transpl Infect Dis 2009; 12:261-264
10. Salmon A, Debourgogne A, Vasbien M, et al. Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature. Clin Microbiol Infect 2010;16:508-512
11. Wiederhold NP, Lewis RE. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi. Med Mycol 2009;47:122-132
12. Cuenca-Estrella M, Alastruey-Izquierdo A, Alcazar-Fuoli L, et al. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob Agents Chemother 2008;52:1136-1139 (Pubitemid 351358399)
13. Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003;47:106-117 (Pubitemid 36070350)
14. Kesson AM, Bellemore MC, O?Mara TJ, Ellis DH, Sorrell TC. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (Miltefosine), in combination with terbinafine and voriconazole: a case report. Clin Infect Dis 2009;48:1257-1261
15. Howden BP, Slavin MA, Schwarer AP, Mijch AM. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003;22:111-113 (Pubitemid 36349974)
16. Ortoneda M, Capilla R, Pastor FJ, Serena C, Guarro J. Interaction of granulocyte colony-stimulating factor and high dose of liposomal amphotericin B in the treatment of systemic murine scedosporiosis. Diagn Microbiol Infect Dis 2004;50:247-251 (Pubitemid 39593147)
17. Stimitsopoulou M, Gil-Lamaignere C, Avramidis N, et al. Antifungal activity of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans. Antimicrob Agents Chemother 2004;48:3801-3805 (Pubitemid 39304606)